PPH vs. VIRS
Compare and contrast key facts about VanEck Vectors Pharmaceutical ETF (PPH) and Pacer BioThreat Strategy ETF (VIRS).
PPH and VIRS are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. VIRS is a passively managed fund by Pacer Advisors that tracks the performance of the LifeSci BioThreat Strategy Index. It was launched on Jun 24, 2020. Both PPH and VIRS are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PPH or VIRS.
Performance
PPH vs. VIRS - Performance Comparison
Returns By Period
PPH
9.00%
-6.61%
-2.86%
14.42%
9.32%
4.96%
VIRS
N/A
N/A
N/A
N/A
N/A
N/A
Key characteristics
| PPH | VIRS |
|---|
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PPH vs. VIRS - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is lower than VIRS's 0.70% expense ratio.
Correlation
The correlation between PPH and VIRS is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
PPH vs. VIRS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and Pacer BioThreat Strategy ETF (VIRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PPH vs. VIRS - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 1.84%, while VIRS has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Vectors Pharmaceutical ETF | 1.84% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
VIRS Pacer BioThreat Strategy ETF | 0.83% | 0.97% | 0.00% | 0.67% | 0.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PPH vs. VIRS - Drawdown Comparison
Volatility
PPH vs. VIRS - Volatility Comparison
VanEck Vectors Pharmaceutical ETF (PPH) has a higher volatility of 3.94% compared to Pacer BioThreat Strategy ETF (VIRS) at 0.00%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than VIRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.